National Health (Listed drugs on F1 or F2) Amending Determination 2018 (No. 7) (PB 81 of 2018) (Cth)

PB 81 of 2018

National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 7)

National Health Act 1953

I, SEAN LANE, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated         28 August 2018

SEAN LANE

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 7).

(2)   This Determination may also be cited as PB 81 of 2018.

1. Commencement

This Determination commences on 1 September 2018.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Balsalazide

Insert

Baricitinib

[2]     Schedule 1, after item dealing with Griseofulvin

Insert

Guanfacine

[3]     Schedule 1, after item dealing with Perampanel

Insert

Perfluorohexyloctane